skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 16,211  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Material Type:
Article
Add to My Research

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

The New England journal of medicine, 2021-04, Vol.384 (14), p.1372-1374 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/nejmc2101667 ;PMID: 33691060

Full text available

2
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Material Type:
Article
Add to My Research

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Nature reviews. Immunology, 2021-08, Vol.21 (8), p.485-498 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00490-y ;PMID: 33526920

Full text available

3
Self-amplifying RNA vaccines for infectious diseases
Material Type:
Article
Add to My Research

Self-amplifying RNA vaccines for infectious diseases

Gene therapy, 2021-04, Vol.28 (3-4), p.117-129 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2020. ;The Author(s), under exclusive licence to Springer Nature Limited 2020 ;ISSN: 0969-7128 ;EISSN: 1476-5462 ;DOI: 10.1038/s41434-020-00204-y ;PMID: 33093657

Full text available

4
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Material Type:
Article
Add to My Research

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

Vaccine, 2022-06, Vol.40 (26), p.3516-3527 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2022 Elsevier Ltd. 2022 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2022.04.069 ;PMID: 35595662

Full text available

5
Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination
Material Type:
Article
Add to My Research

Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination

Hypertension (Dallas, Tex. 1979), 2022-10, Vol.79 (10), p.e132-e134 [Peer Reviewed Journal]

2022 The Authors. 2022 ;ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/hypertensionaha.122.19694 ;PMID: 35862106

Full text available

6
Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature
Material Type:
Article
Add to My Research

Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature

Digestive diseases and sciences, 2022-09, Vol.67 (9), p.4574-4580 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 ;2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;COPYRIGHT 2022 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. ;ISSN: 0163-2116 ;EISSN: 1573-2568 ;DOI: 10.1007/s10620-022-07504-w ;PMID: 35486203

Full text available

7
Some lessons from 18 months of COVID vaccination
Material Type:
Article
Add to My Research

Some lessons from 18 months of COVID vaccination

M.S. Médecine sciences, 2022-10, Vol.38 (10), p.761-762 [Peer Reviewed Journal]

EISSN: 1958-5381 ;DOI: 10.1051/medsci/2022132 ;PMID: 36219072

Full text available

8
Severe mental illness: reassessing COVID-19 vaccine priorities
Material Type:
Article
Add to My Research

Severe mental illness: reassessing COVID-19 vaccine priorities

The Lancet (British edition), 2021-02, Vol.397 (10275), p.657-657 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00429-3 ;PMID: 33610199

Full text available

9
Masks and closed-loop ventilators prevent environmental contamination by COVID-19 patients in negative-pressure environments
Material Type:
Article
Add to My Research

Masks and closed-loop ventilators prevent environmental contamination by COVID-19 patients in negative-pressure environments

Journal of microbiology, immunology and infection, 2021-02, Vol.54 (1), p.81-84 [Peer Reviewed Journal]

2020 ;2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. ;2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2020 ;ISSN: 1684-1182 ;EISSN: 1995-9133 ;DOI: 10.1016/j.jmii.2020.05.002 ;PMID: 32425995

Full text available

10
Development post-Covid-19: memory, discernment, humanism, ethics, science and nature
Material Type:
Article
Add to My Research

Development post-Covid-19: memory, discernment, humanism, ethics, science and nature

Revista portuguesa de cardiologia, 2021-05, Vol.40 (5), p.311 [Peer Reviewed Journal]

EISSN: 2174-2030 ;DOI: 10.1016/j.repc.2020.10.006 ;PMID: 33461843

Full text available

11
Comment prendre le pas sur le coronavirus dans un pays en développement: questions et actions au Burkina Faso
Material Type:
Article
Add to My Research

Comment prendre le pas sur le coronavirus dans un pays en développement: questions et actions au Burkina Faso

The Pan African medical journal, 2020, Vol.35 (Suppl 2), p.37-37 [Peer Reviewed Journal]

Emmanuelle Semporé et al. ;Emmanuelle Semporé et al. 2020 ;EISSN: 1937-8688 ;DOI: 10.11604/pamj.supp.2020.35.2.23033 ;PMID: 33623562

Full text available

12
COVID-19 vaccines increase the risk of anaphylaxis
Material Type:
Article
Add to My Research

COVID-19 vaccines increase the risk of anaphylaxis

Tidsskrift for den Norske Lægeforening, 2021-03, Vol.141 (4) [Peer Reviewed Journal]

EISSN: 0807-7096 ;DOI: 10.4045/tidsskr.21.0109 ;PMID: 33685103

Full text available

13
Fight against COVID-19: market overview and pipeline of ongoing trials
Material Type:
Article
Add to My Research

Fight against COVID-19: market overview and pipeline of ongoing trials

M.S. Médecine sciences, 2020-12, Vol.36 (12), p.1225-1232 [Peer Reviewed Journal]

EISSN: 1958-5381 ;DOI: 10.1051/medsci/2020231 ;PMID: 33211647

Full text available

14
The Saga of Vaccines against Covid-19
Material Type:
Article
Add to My Research

The Saga of Vaccines against Covid-19

Bulletin de la Société de pathologie exotique (1990), 2020, Vol.113 (4), p.185-186 [Peer Reviewed Journal]

EISSN: 1961-9049 ;DOI: 10.3166/bspe-2020-0149 ;PMID: 33826275

Full text available

15
Face à la COVID-19. Myocardite dans les suites d’une vaccination à mRNA SARS-CoV-2
Material Type:
Web Resources
Add to My Research

Face à la COVID-19. Myocardite dans les suites d’une vaccination à mRNA SARS-CoV-2

ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 36924151

Full text available

16
Face à la COVID-19. Utilisation de la stratégie CEdRIC dans le contexte de la pandémie à coronavirus : retour d’expérience
Material Type:
Web Resources
Add to My Research

Face à la COVID-19. Utilisation de la stratégie CEdRIC dans le contexte de la pandémie à coronavirus : retour d’expérience

ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 35389004

Full text available

17
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
Material Type:
Article
Add to My Research

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression

The Lancet infectious diseases, 2023-05, Vol.23 (5), p.556-567 [Peer Reviewed Journal]

2023 World Health Organization ;2023 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;2023 World Health Organization 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00801-5 ;PMID: 36681084

Full text available

18
Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections
Material Type:
Article
Add to My Research

Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections

The Lancet (British edition), 2021-01, Vol.397 (10269), p.92-93 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32625-8 ;PMID: 33347811

Full text available

19
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
Material Type:
Article
Add to My Research

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

British Journal of Surgery, 2021-09, Vol.108 (9), p.1056-1063 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0007-1323 ;ISSN: 1365-2168 ;EISSN: 1365-2168 ;DOI: 10.1093/bjs/znab101

Digital Resources/Online E-Resources

20
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

Results 1 - 20 of 16,211  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (15,814)

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (1,290)
  3. 2021 To 2021  (4,395)
  4. 2022 To 2023  (9,160)
  5. After 2023  (1,366)
  6. More options open sub menu

Language 

  1. English  (16,131)
  2. Japanese  (1,170)
  3. Portuguese  (147)
  4. Spanish  (101)
  5. French  (37)
  6. Norwegian  (35)
  7. Chinese  (25)
  8. Russian  (6)
  9. Polish  (4)
  10. Korean  (4)
  11. Italian  (2)
  12. Catalan  (2)
  13. Croatian  (2)
  14. Swedish  (1)
  15. German  (1)
  16. Turkish  (1)
  17. Bosnian  (1)
  18. More options open sub menu

Searching Remote Databases, Please Wait